Histone methyltransferase inhibitors: orally bioavailable, fast acting molecules with activity against different human malaria species.
Current antimalarials are under continuous threat due to the relentless development of drug resistance by malaria parasites. We previously reported promising in vitro parasite killing activity with the histone methyltransferase inhibitor BIX-01294 and its analogue TM2-115. Here we further characteri...
Main Authors: | Malmquist, N, Sundriyal, S, Caron, J, Chen, P, Witkowski, B, Menard, D, Suwanarusk, R, Renia, L, Nosten, F, Jiménez-Díaz, M, Angulo-Barturen, I, Martínez, MS, Ferrer, S, Sanz, L, Gamo, F, Wittlin, S, Duffy, S, Avery, V, Ruecker, A, Delves, M, Sinden, R, Fuchter, M, Scherf, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2014
|
Similar Items
-
Fueling Open Innovation for Malaria Transmission-Blocking Drugs: Hundreds of Molecules Targeting Early Parasite Mosquito Stages
by: Michael Delves, et al.
Published: (2019-09-01) -
Fueling open innovation for malaria transmission-blocking drugs: hundreds of molecules targeting early parasite mosquito stages
by: Delves, M, et al.
Published: (2019) -
On the histone lysine methyltransferase activity of fungal metabolite chaetocin.
by: Cherblanc, F, et al.
Published: (2013) -
The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites.
by: Delves, M, et al.
Published: (2012) -
A semi-automated method for counting fluorescent malaria oocysts increases the throughput of transmission blocking studies
by: Delves, M, et al.
Published: (2010)